DNA repair defects and implications for immunotherapy

Research output: Contribution to journalReview article

Abstract

A complex DNA repair machinery has evolved to protect genomic integrity in the face of a myriad of DNA damage sources. When DNA repair fails, this damage can lead to carcinogenesis and tumor genomic instability. Indeed, many heritable cancer predisposition syndromes are attributable to germline defects in DNA repair pathways. On the other hand, these defects may also portend particular vulnerabilities of the cancer and may be exploited therapeutically. Most recently this has been demonstrated in the case of mismatch repair-deficient cancers, in which the immune checkpoint inhibitors have been demonstrated to be highly active. This observation has paved the way for further research investigating other sources of genomic instability that may serve as biomarkers to select patients for immunotherapy.

Original languageEnglish (US)
Pages (from-to)4236-4242
Number of pages7
JournalJournal of Clinical Investigation
Volume128
Issue number10
DOIs
Publication statusPublished - Oct 1 2018

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this